Related Experiment Video
Updated: Jun 19, 2026

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Late prosthetic valve endocarditis
D Horstkotte1, C Piper, R Niehues
1Department of Cardiology, University Hospital Benjamin Franklin, Berlin, Germany.
Abstract:
Prosthetic valve endocarditis remains an extremely serious complication, with a low but increasing incidence. 'Late' endocarditis, occurring more than 60 days after surgery, is relatively infrequently associated with staphylococci, Gram-negative bacteria and fungi so characteristic of the endocarditis that occurs earlier. A probable source of infection can be found in 25%-80% of patients, the most frequent causes being dental procedures, urological infections and interventions, and indwelling catheters. The most common organisms are S. epidermidis, S. aureus, viridans streptococci and enterococci. The general principles of antibiotic treatment are similar to those for native valve endocarditis, but antibiotic treatment needs to be more prolonged and dosages should be used which result in maximal, nontoxic concentrations. Oral anticoagulants should be stopped and replaced by intravenous heparins. Surgical reintervention is called for if there are large highly mobile vegetations in the mitral position or within 72 h if there are cerebral thrombo-embolic episodes.
Insights
Prosthetic valve endocarditis (PVE) is a serious complication. Late PVE, occurring after 60 days, involves different organisms and requires prolonged antibiotic therapy and careful management of anticoagulation and surgical intervention.
Area of Science:
- Cardiology
- Infectious Diseases
- Cardiac Surgery
Background:
- Prosthetic valve endocarditis (PVE) is a severe complication following valve replacement surgery.
- Late PVE, defined as occurring >60 days post-surgery, presents distinct microbiological and clinical characteristics compared to early PVE.
- Identifying infection sources is crucial, with dental procedures, urological interventions, and catheters being common culprits.
Purpose of the Study:
- To summarize the characteristics, common pathogens, and management principles of late prosthetic valve endocarditis.
- To highlight differences in causative organisms between early and late PVE.
- To outline current treatment strategies, including antibiotic therapy, anticoagulation, and surgical indications.
Main Methods:
- Review of existing literature on prosthetic valve endocarditis.
- Analysis of common bacterial and fungal organisms associated with late PVE.
- Comparison of treatment protocols for native and prosthetic valve endocarditis.
Main Results:
- Late PVE is less frequently associated with staphylococci, Gram-negative bacteria, and fungi compared to early PVE.
- Commonly implicated organisms in late PVE include S. epidermidis, S. aureus, viridans streptococci, and enterococci.
- Antibiotic therapy for late PVE requires prolonged duration and maximal non-toxic concentrations.
Conclusions:
- Management of late PVE necessitates extended antibiotic courses and careful monitoring.
- Oral anticoagulants should be discontinued and replaced with intravenous heparin.
- Surgical intervention is indicated for large mobile vegetations or embolic events.
More Related Videos
Related Concept Videos
Mitral Stenosis I: Introduction
Mitral Stenosis III: Medical Management
Endocarditis I: Introduction
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management

